Verhoeff Kevin, Dang Jerry T, Deprato Andy, Kung Janice Y, Switzer Noah J, Birch Daniel W, Wong Clarence, Karmali Shahzeer
Department of Surgery, University of Alberta, Edmonton, AB, Canada.
Division of General Surgery, Department of Surgery, University of Alberta, University of Alberta Hospital, 8440 112 Street NW, Edmonton, AB, T6G 2B7, Canada.
Surg Endosc. 2021 Dec;35(12):7154-7162. doi: 10.1007/s00464-020-08135-w. Epub 2020 Nov 6.
Cameron lesions (CL) are an under-recognized cause of gastrointestinal bleeding. Diagnosis is often impaired by technical difficulty, and once diagnosed, management remains unclear. Typically, patients are medically managed with proton pump inhibitors (PPI). Small studies have demonstrated improved therapeutic success with surgical management, hypothesizing that reversing mechanical gastric trauma and ischemia allows CL healing. This systematic review and meta-analysis aim to compare therapeutic success of surgical versus medical management of Cameron lesions (CL).
A comprehensive search and systematic review selected manuscripts using the following inclusion criteria: (1) Endoscopically diagnosed CL (2) Treated surgically (3) Follow-up for resolution of anemia or CL (4) n ≥ 5 (5) Excluding non-English, animal, and studies with patients < 18 years old Meta-analysis was performed to compare resolution of CLs with medical and surgical therapy.
Systematic search retrieved 1664 studies, of these, 14 were included (randomized controlled trial = 1; prospective = 2; retrospective = 11). Patients had a mean age of 61.2 years (range 24-91) and were more often female (59.3%). Follow-up was between 3 and 120 months, and 82.9% of patients had hernias > 5 cm. Surgical management was associated with therapeutic success (OR 5.20, 1.83-14.77, I = 42%, p < 0.001) with 92% having resolution, compared to 67.2% for those treated with PPI. Surgical complications occurred in 42/109 (38.5%) of patients (48.1% for Open Hill Repair, 15.4% for laparoscopic fundoplication). 40.0% of patients underwent a laparoscopic Nissen or Collis fundoplication, 21.7% underwent open modified Hill repair, and 38.3% had unspecified operations. Hemoglobin improved from 8.85 g/dL pre-operatively to 13.60 g/dL post-operatively. In six studies, surgical patients previously failed medical management.
This is the first systematic review comparing surgical and medical treatment of CL. Surgical management significantly improved therapeutic success. Our study supports therapeutic benefit of surgery in these patients.
卡梅伦病变(CL)是胃肠道出血的一个未被充分认识的原因。诊断常常因技术困难而受到影响,一旦确诊,治疗方案仍不明确。通常情况下,患者采用质子泵抑制剂(PPI)进行药物治疗。小型研究表明,手术治疗的治疗成功率更高,推测逆转机械性胃损伤和缺血可使CL愈合。本系统评价和荟萃分析旨在比较卡梅伦病变(CL)手术治疗与药物治疗的治疗成功率。
通过全面检索和系统评价,选择符合以下纳入标准的手稿:(1)经内镜诊断为CL;(2)接受手术治疗;(3)随访贫血或CL的缓解情况;(4)n≥5;(5)排除非英文、动物及患者年龄<18岁的研究。进行荟萃分析以比较CL通过药物和手术治疗的缓解情况。
系统检索共获得1664项研究,其中14项被纳入(随机对照试验=1项;前瞻性研究=2项;回顾性研究=11项)。患者的平均年龄为61.2岁(范围24-91岁),女性更为常见(59.3%)。随访时间为3至120个月,82.9%的患者疝>5cm。手术治疗与治疗成功相关(OR 5.20,1.83-14.77,I=42%,p<0.001),92%的患者病情缓解,而接受PPI治疗的患者缓解率为67.2%。42/109(38.5%)的患者发生手术并发症(开放式希尔修复术为48.1%,腹腔镜胃底折叠术为15.4%)。40.0%的患者接受了腹腔镜nissen或科利斯胃底折叠术,21.7%的患者接受了开放式改良希尔修复术,38.3%的患者接受了未明确的手术。血红蛋白术前为8.85g/dL,术后升至13.60g/dL。在六项研究中,手术患者之前药物治疗失败。
这是第一项比较CL手术和药物治疗的系统评价。手术治疗显著提高了治疗成功率。我们的研究支持对这些患者进行手术治疗的益处。